• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Novo Nordisk

NYSE:NVO

$140.61 $0.70 (0.50%)

REAL-TIME: Last trade at

Novo Nordisk A/S Diabetes Drug Gets FDA Nod for Toddlers

Insulin Pill for Diabetics Seen as $10 Billion Holy Grail for Novo Nordisk A/S

Novo Nordisk Diabetes Drug Approved For Toddlers

Novo Nordisk's Levemir approved for wider pediatric use

Novo Nordisk announces FDA expands use of Levemir for children

FDA Approves Levemir® for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes

Company news: Novo Nordisk and Health Union

Novo Nordisk Celebrates New INDYCAR Partnership Featuring Indy 500-Themed Billboard in Times Square

The Incredible Shrinking Salesforce? Not Everywhere - Big Drugmakers Like Boehringer Ingelheim Corporation, Novo Nordisk A/S are Still Hiring!

Novo Nordisk Celebrates New INDYCAR Partnership Featuring Indy 500-Themed Billboard in Times Square

Research and License Agreements between National Cheng Kung University and Novo Nordisk A/S

Research and License Agreements between National Cheng Kung University and Novo Nordisk A/S

Emisphere Technologies, Inc. Announces Financial Results for First Quarter Ended March 31, 2012

Novo Nordisk Inc. Appoints Robert Clark as Vice President, Regulatory Affairs

Novo Nordisk A/S Steps Up Research to Find Cure for Diabetes, Plans to Hire More Researchers

Novo Nordisk steps up research on diabetes

Novo Nordisk A/S Says Blood Drugs Could Hold Blockbuster Potential

Novo Nordisk to buy back 4.2B kroner shares

Growing Novo Nordisk inks $100M tech deal, boasts of blockbuster hopefuls

Novo Nordisk, Caisson Biotech enter into development and license agreement

Caisson Biotech Enters into Development and License Agreement with Novo Nordisk

Novo Nordisk Losing Its Sugar High?

NVO Kicks Off 2012 on a Strong Note

Kilburg's Take on the Markets

Novo Nordisk plans hiring spree as Q1 sales jump 10%

Novo Nordisk to add 615 jobs

Novo Nordisk to add 615 jobs

Novo Nordisk Finally Looks (Slightly) Mortal

UPDATED: Novo Nordisk hiring R&D, other workers in U.S. recruitment blitz

Novo Nordisk A/S to Boost US Workforce by 15 Percent in 2012

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Novo Nordisk misses views, shares fall

81% rise in Victoza sales drives Novo Nordisk earnings

Novo Nordisk plans 15 percent expansion of U.S. work force in 2012

Novo Nordisk plans 15 percent expansion of U.S. work force in 2012

Novo Nordisk Profit Misses Analyst Expectations

Forecast: Top 15 Pharma Companies in 2018

Novo Nordisk Honored as a Best Place to Work in New Jersey

Barclays Downgrades Novo Nordisk (NVO) to Underweight

Will Amylin Stand To Gain From A Citizen's Petition Challenging Victoza?

See More Articles...